Holly Kordasiewicz
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Holly Kordasiewicz is currently Chief Development Officer & Executive VP at Ionis Pharmaceuticals, Inc., a position held since 2026.
Education includes an undergraduate degree from State University of New York College at Geneseo and a doctorate from the University of Minnesota.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2026 | 22.458 ( 0,01 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
State University of New York College at Geneseo
State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.